Blood substitutes as pharmacotherapies in clinical practice

Current Opinion in Anaesthesiology

Volumn 20, Issue 4, 2007, Pages 325-330

  Jahr, Jonathan S ^a,b   Walker, Valeri ^a   Manoochehri, Katayoon ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood substitutes; Hemoglobin based oxygen carriers; Oxygen therapeutics; Perfluorocarbons

Indexed keywords

BLOOD SUBSTITUTE; DIASPIRIN CROSSLINKED HEMOGLOBIN; FLUOROCARBON; FLUOSOL; FLUOSOL DA; HEMEASSIST; HEMOGEN; HEMOGLOBIN; HEMOGLOBIN BASED OXYGEN CARRIER; HEMOSPAN; OXYGEN; OXYGLOBIN; OXYVITA; PERFLUOROOCTYL BROMIDE; PERFTORAN; POLYMERIZED HEMOGLOBIN; SILICONE; UNCLASSIFIED DRUG;

AORTA RECONSTRUCTION; ARTERIAL PRESSURE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CARDIOPULMONARY BYPASS; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG EFFICACY; FLU LIKE SYNDROME; GASTROINTESTINAL SYMPTOM; HEMOCHROMATOSIS; HEMODYNAMICS; HEPATIC ENGORGEMENT; HUMAN; IMMUNOPATHOLOGY; IRON OVERLOAD; LUNG VASCULAR RESISTANCE; MACROPHAGE FUNCTION; MORBIDITY; MORTALITY; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; ORTHOPEDIC SURGERY; OSMOSIS; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SYSTEMIC VASCULAR RESISTANCE; THROMBOCYTE AGGREGATION; VASOCONSTRICTION;

BLOOD SUBSTITUTES; BLOOD TRANSFUSION; FLUOROCARBONS; HEMOGLOBINS; HUMANS; OXYGEN;

EID: 34447325354     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e328172225a     Document Type: Review

References (39)

1. Jahr JS, Nesargi S, Lewis K, Johnson C. Blood substitutes and oxygen therapeutics: An overview and current status. Am J Ther 2002; 9:437-443.
2. Brander L, Reil A, Bux J, et al. Severe transfusion-related acute lung injury. Anesth Analg 2005; 101:499-501.
3. Landers DF, Hill GE, Wong KC, et al. Blood transfusion induced immunomodulation. Anesth Analg 1996; 82:187-204.
4. Weber EW, Slappendel R, Prins MH, et al. Perioperative blood transfusions and delayed wound healing after hip replacement surgery; effects on duration of hospitalization. Anesth Analg 2005; 100:1416-1421.
5. Tobias JD. Strategies for minimizing blood loss in orthopedic surgery. Semin Hematol 2004; 41 (1 Suppl 1):145-156.
6. Purdue FR, Tweedale MC, Merrick PM. Association of mortality with age of blood transfusion in septic ICU patients. Can J Anaesth 1997; 44:1256-1261.
7. Hébert PC, Chin-Yee I, Fergusson D, et al., and the Canadian Critical Care Trials Group. A pilot trial evaluating the clinical effects of prolonged storage of red cells. Anesth Analg 2005; 100:1433-1458.
8. Practice Guidelines for Perioperative Blood Transfusion and Adjuvant Therapies: An Updated Report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006; 105:198-208. This reference is critical reading for any practitioner transfusing blood and blood products.
9. Shore-Lesserson L, Manspeizer HE, DePerio M, et al. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999; 88:312-320.
10. Spahn DR, Casutt M. Eliminating blood transfusions. Anesthesiology 2000; 93:242-255.
11. Barrons RW, Jahr JS. Aprotinin and antifibrinolytics in cardiopulmonary bypass bleeding. Semin Anesth Periop Med Pain 1998; 17:224-238.
12. Winslow R. Red cell substitutes. Semin Hematol 2007; 44:51-59. Important review and introduction to new generation HBOCs.
13. Remy B, Deby-Dupont G, Lamy M. Red blood cell substitutes: fluorocarbon emulsions and hemoglobin solutions. Br Med Bull 1999; 55:277-298.
14. Fromm RE Jr. Blood substitutes. Crit Care Med 2000; 28:2150-2151.
15. Chang TMS. Modified hemoglobin blood substitutes: present status and future perspectives. Biotech Annu Rev 1998; 4:75-112.
16. Schubert A, Przybelski RJ, Eidt JF, et al. Diaspirin-crosslinked hemoglobin reduces blood transfusion in noncardiac surgery: a multicenter, randomized, controlled, double-blinded trial. Anesth Analg 2003; 97:323-332.
17. Driessen B, Jahr JS, Lurie F, et al. Effects of hemoglobin-based oxygen carrier Hemoglobin glutamer-200 (bovine) on intestinal perfusion and oxygenation in a canine hypovolemia model. Br J Anaesth 2001; 86:683-692.
18. Kasper SM, Walter M, Grune F, et al. Effects of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth Analg 1996; 83:921-927.
19. Greenburg AG, Kim HW, Hemolink Study Group. Use of an oxygen therapeutic as an adjunct to intraoperative autologous donation to reduce transfusion requirements in patients undergoing coronary artery bypass graft surgery. J Am Coll Surg 2004; 198:373-383.
20. Levy JH, Goodnough LT, Greilich PE, et al. Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: Results of a randomized, double-blind trial. J Thorac Cardiovasc Surg 2002; 124:35-42.
21. Jahr JS, Lurie F, Xi S, et al. A novel approach to measuring circulating blood volume: use of a hemoglobin-based oxygen carrier (HBOC) in a rabbit model. Anesth Analg 2001; 92:609-614.
22. Matheson B, Kwansa H, Bucci E, et al. Vascular response to infusions of a nonextravasating hemoglobin polymer. J Appl Physiol 2002; 93:1479-1486.
23. Bjorkholm M, Fagrell B, Przybelski R, et al. A phase I, single, blind clinical trial of a new oxygen transport agent (MP4), human hemoglobin modified with maleimide-activated polyethylene glycol. Haematologica 2005; 90:505-515.
24. Chang TMS. Is there a need for blood substitutes in the new millennium, and what should we expect in the way of safety and efficacy [editorial]? Artif Cells Blood Substit Immobil Biotechnol 2000; 28:i-vii.
25. Clark LC Jr, Gollan F. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science 1966; 152:1755-1756.
26. Chang TMS. Semipermeable aqueous microcapsules ("artificial cells"): with emphasis on experiments in an extracorporeal shunt system. Trans Am Soc Artif Intern Organs 1966; 12:13-19.
27. Slovitier H, Kamimoto T. Erythrocyte substitute for perfusion of brain. Nature 1967; 216:458-460.
28. Geyer RP, Monroe RG, Taylor K. Survival of rats totally perfused with a fluorocarbon detergent preparation. In: Norman JC, Folkman J, Hardison WG, editors. Organ Perfusion and Preservation. New York: Appleton Century Crofts; 1968. pp. 85-96.
29. Naito R, Yokoyama K. An improved perflurodecalin emulsion. In: Jamieson GA, Greenwalt TJ, editors. Blood Substitutes and Plasma Expanders. New York: Alan R. Liss; 1978. pp. 81-85.
30. Dietz NM, Joyner MJ, Warner MA. Blood substitutes; fluids, drugs or miracle solutions? Anesth Analg 1996; 82:390-405.
31. Jai L, Bonaventura C, Bonaventura J, et al. Protein S-nitrosohemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996; 380:221-226.
32. Cole DJ, Nary JC, Reynolds LW, et al. Experimental subarachnoid hemorrhage in rats: effects of intravenous alpha-alpha diaspirin cross-linked hemoglobin on hypoperfusion and neuronal death. Anesthesiology 1997; 87:1486-1493.
33. Lurie F, Driessen B, Jahr JS, et al. Validity of arterial and mixed venous oxygen saturation measurements in a canine hemorrhage model after resuscitation with varying concentrations of hemoglobin-based oxygen carrier. Anesth Analg 2003; 96:46-50.
34. Jahr JS, Osgood S, Rothenberg SJ, et al. Lactate interference by hemoglobinbased oxygen carriers (Oxyglobin®, Hemopure® and Hemolink™). Anesth Analg 2005; 100:431-436.
35. Jahr JS, on behalf of the entire study team, Biopure Corporation. A novel blood substitute: Use of HBOC-201 (Hemopure™) to decrease need for RBC: Results of pivotal trial in orthopedic surgery patients. Crit Care Med 2002; 29:S243.
36. Jahr JS, Dulchavsky SA, Garino JP, et al. Hemodynamic Effects of Hemoglobin Glutamer-250 (Hemopure™, HBOC-201) Compared to Red Blood Cells in Pivotal Safety and Efficacy Study in Orthopedic Surgery Patients. Anesth Analg 2002; 94:S-330.
37. Jahr JS, Steward LM, MacKenzie C, et al. Pivotal Phase III Study: Safety of Polymerized Bovine Hemoglobin (HBOC-201, Hemopure® as Compared to RBC in Patients Undergoing Orthopedic Surgery. Anesthesiology 2002; 96:A243.
38. Jahr JS, Weeks DL, Desai P, et al. Does OxyVita™, a New Generation HBOC or Oxyglobin® Acutely Interfere with Coagulation Compared to Normal Saline or 6% Hetastarch: An Ex-vivo TEG Preliminary Study. J Cardiothorac Vasc Anesth (in press).
39. Jahr JS, Varma N. PolyHeme. IDrugs 2004; 7:478-482.